| [1] |
Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience[J]. Ann Surg, 2011, 253(4):745-758.
|
| [2] |
Toso C, Mentha G, Majno P. Liver transplantation for hepatocellular carcinoma: five steps to prevent recurrence[J]. Am J Transplant, 2011, 11(10):2031-2035.
|
| [3] |
Wang CC, Iyer SG, Low JK, et al. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma[J]. Ann Surg Oncol, 2009, 16(7):1832-1842.
|
| [4] |
Yamashita T, Forgues M, Wang W, et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma[J]. Cancer Res, 2008, 68(5):1451-1461.
|
| [5] |
Bednarz-Knoll N, Alix-Panabières C, Pantel K. Plasticity of disseminating cancer cells in patients with epithelial malignancies[J]. Cancer Metastasis Rev, 2012, 31(3/4):673-687.
|
| [6] |
Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 2008, 133(4):704-715.
|
| [7] |
Sun YF, Xu Y, Yang XR, et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection[J]. Hepatology, 2013, 57(4):1458-1468.
|
| [8] |
Schulze K, Gasch C, Staufer K, et al. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma[J]. Int J Cancer, 2013, 133(9):2165-2171.
|
| [9] |
Guo W, Yang XR, Sun YF, et al. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform[J]. Clin Cancer Res, 2014, 20(18):4794-4805.
|
| [10] |
Liu S, Li N, Yu X, et al. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells[J]. Gastroenterology, 2013, 144(5):1031-1041.
|
| [11] |
Fan ST, Yang ZF, Ho DW, et al. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study[J]. Ann Surg, 2011, 254(4):569-576.
|
| [12] |
Xu W, Cao L, Chen L, et al. Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy[J]. Clin Cancer Res, 2011, 17(11):3783-3793.
|
| [13] |
Lu J, Fan T, Zhao Q, et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients[J]. Int J Cancer, 2010, 126(3):669-683.
|
| [14] |
Fan JL, Yang YF, Yuan CH, et al. Circulating tumor cells for predicting the prognostic of patients with hepatocellular carcinoma: a meta analysis[J]. Cell Physiol Biochem, 2015, 37(2):629-640.
|
| [15] |
Bahnassy AA, Zekri AR, El-Bastawisy A, et al. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease[J]. World J Gastroenterol, 2014, 20(48):18240-18248.
|
| [16] |
Liu HY, Qian HH, Zhang XF, et al. Improved method increases sensitivity for circulating hepatocellular carcinoma cells[J]. World J Gastroenterol, 2015, 21(10):2918-2925.
|
| [17] |
Li J, Chen L, Zhang X, et al. Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin[J]. PLoS One, 2014, 9(4):e96185.
|
| [18] |
Newman AM, Bratman SV, To J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage[J]. Nat Med, 2014, 20(5):548-554.
|
| [19] |
Kelley RK, Magbanua MJ, Butler TM, et al. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls[J]. BMC Cancer, 2015(15):206.
|